Summary

The Medical Tourism Market is projected to reach USD 2,92,866.10 million by 2035, expanding at a CAGR of 18.02% during 2025-2035. Medical tourism is the concept of patients who travel abroad to get medical care or procedures.

Rising Patient Awareness
Patients' awareness about medical tourism has gone up significantly since they can now access online information, reviews, and various medical tourism platforms.

Segment-Wise Market Classification
Treatment Type
- Orthopaedic: Bone, spine, and joint treatment demand
- Oncology: Growing cross-border cancer treatment adoption
- Cosmetic Surgery: Rising demand for aesthetic procedures
- Epilepsy: Specialized care for chronic neurological conditions
- Cardiovascular: Increasing medical travel for heart care
- Dentistry: Dental procedures driving short-term medical travel
- Neurology: Complex neurological treatments with expert specialists
- Fertility: High demand for reproductive medical services
- Others: Diverse treatments supporting overall market growth
Service Provider
- Public: Cost-efficient care through public institutions
- Private: Patient-centric services with global standards

Regional Analysis
Medical tourism growth is driven by the increasing outbound demand from North America and Europe as a result of the high costs and long waits in these regions. Asia-Pacific is the leading destination, with the Middle East quickly gaining ground.

Future Opportunities
The utilisation of telemedicine, virtual check-ups, and hospital partnerships across borders will help to build confidence, ensure continuity of care, and support the growth of the market over time.

Key Report Attributes
- Market Size 2024: USD 49,279.57 Million
- Market Size 2035: USD 2,92,866.10 Million
- CAGR (2025-2035): 18.02%
- Base Year: 2024
- Market Forecast Period: 2025-2035

Industry Segmentations Growth
- By Treatment Type: Orthopaedic - 16.11%, Oncology - 14.41%.
- By Service Provider: Public - 16.25%, Private - 18.94%.

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY ..... 30
2 MARKET INTRODUCTION ........ 32
2.1 DEFINITION ....... 32
2.2 SCOPE OF THE STUDY ....... 32
2.3 RESEARCH OBJECTIVE ..... 32
2.4 MARKET STRUCTURE ....... 32
3 RESEARCH METHODOLOGY ....... 33
3.1 OVERVIEW .... 33
3.2 DATA FLOW ....... 35
3.2.1 DATA MINING PROCESS .... 35
3.3 PURCHASED DATABASE: ....... 36
3.4 SECONDARY SOURCES: ..... 37
3.4.1 SECONDARY RESEARCH DATA FLOW: .... 38
3.5 PRIMARY RESEARCH: ........ 39
3.5.1 PRIMARY RESEARCH DATA FLOW: ........ 40
3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED ........ 41
3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE ........ 41
3.6 APPROACHES FOR MARKET SIZE ESTIMATION: ...... 42
3.6.1 REVENUE ANALYSIS APPROACH ....... 42
3.7 DATA FORECASTING..... 43
3.7.1 DATA FORECASTING TYPE ...... 43
3.8 DATA MODELING ....... 44
3.8.1 MICROECONOMIC FACTOR ANALYSIS: ........ 44
3.8.2 DATA MODELING: .... 45
3.9 TEAMS AND ANALYST CONTRIBUTION ....... 47
4 MARKET DYNAMICS ...... 49
4.1 INTRODUCTION ..... 49
4.2 DRIVERS .... 50
4.2.1 RISING AWARENESS ABOUT MEDICAL TOURISM AMONG PATIENTS ..... 50
4.2.2 LOW COST OF MEDICAL TREATMENT IN DEVELOPING COUNTRIES ...... 50
4.3 RESTRAINTS ..... 52
4.3.1 ISSUE WITH PATIENT FOLLOW-UP AND POST-SURGERY COMPLICATIONS ...... 52
4.3.2 QUALITY, SAFETY, AND ETHICAL CONCERNS ........ 53
4.4 OPPORTUNITY ....... 55
4.4.1 EXPANSION OF TELEMEDICINE AND VIRTUAL CONSULTATIONS ..... 55
4.4.2 CROSS-BORDER COLLABORATIONS AND HOSPITAL PARTNERSHIPS .... 55
5 INDUSTRY TREND ANALYSIS ...... 57
5.1 REGULATORY ENVIRONMENT & COMPLIANCE ........ 57
5.2 MARKET TRENDS & INNOVATION ........ 58
5.3 MARKET ENTRY & EXIT BARRIERS ...... 59
5.3.1 BARRIERS TO ENTRY .... 59
5.3.2 BARRIERS TO EXIT ........ 59
5.4 PRICING ANALYSIS & REIMBURSEMENT DYNAMICS ....... 60
5.4.1 PRICING ANALYSIS ....... 60
5.4.1.1 NORTH AMERICA ...... 60
5.4.1.1.1 NORTH AMERICA PRICING ANALYSIS, BY PROCEDURE ...... 60
5.4.1.2 EUROPE ..... 60
5.4.1.2.1 EUROPE PRICING ANALYSIS, BY PROCEDURE ..... 60
5.4.1.3 APAC .... 60
5.4.1.3.1 APAC PRICING ANALYSIS, BY PROCEDURE ........ 60
5.4.1.4 REST OF THE WORLD ...... 61
5.4.1.4.1 REST OF THE WORLD PRICING ANALYSIS, BY PROCEDURE ..... 61
5.4.2 REIMBURSEMENT DYNAMICS ...... 61
5.5 PARTNERSHIPS & COLLABORATIONS ....... 61
5.6 PESTLE ANALYSIS .... 62
5.6.1 POLITICAL FACTORS .... 62
5.6.2 ECONOMIC FACTORS ........ 62
5.6.3 SOCIAL FACTORS .... 62
5.6.4 TECHNOLOGICAL FACTORS .... 63
5.6.5 LEGAL FACTORS ..... 63
5.6.6 ENVIRONMENTAL FACTORS ........ 63
5.7 PORTER'S FIVE FORCES MODEL ........ 64
5.7.1 THREAT OF NEW ENTRANTS ........ 64
5.7.2 BARGAINING POWER OF SUPPLIERS ...... 64
5.7.3 THREAT OF SUBSTITUTES ...... 65
5.7.4 BARGAINING POWER OF BUYERS (PATIENTS) ........ 65
5.7.5 INTENSITY OF RIVALRY ..... 65
5.8 CASE STUDY ANALYSIS ........ 65
5.9 INVESTMENT & FUNDING SCENARIOS ..... 65
5.10 LIST OF KEY PLAYERS, BY COUNTRY ....... 66
5.10.1 THAILAND ..... 66
5.10.1.1 LIST OF KEY PLAYERS, THAILAND ....... 66
5.10.2 INDIA ....... 66
5.10.2.1 LIST OF KEY PLAYERS, INDIA .... 66
5.10.3 MEXICO ........ 67
5.10.3.1 LIST OF KEY PLAYERS, MEXICO ..... 67
5.10.4 TURKEY .... 67
5.10.4.1 LIST OF KEY PLAYERS, TURKEY ..... 67
5.10.5 MALAYISA .... 67
5.10.5.1 LIST OF KEY PLAYERS, MALAYSIA ...... 67
5.11 QUALITATIVE DATA ON MEDICAL TOURISM ESPECIALLY THE DENTAL TOURISM DATA ..... 68
5.11.1 THAILAND ..... 68
5.11.1.1 COSTS INVOLVED IN THAILAND DENTAL TOURISM ...... 68
5.11.2 INDIA ....... 69
5.11.2.1 COSTS INVOLVED IN INDIAN DENTAL TOURISM ...... 69
5.11.3 TURKEY .... 69
5.11.3.1 COSTS INVOLVED IN TURKEY DENTAL TOURISM ..... 69
5.12 QUALITATIVE ANALYSIS OF LEADING ECONOMIES IN MEDICAL TOURISM ........ 70
5.12.1 INDIA ....... 70
5.12.1.1 KEY REASONS ...... 70
5.12.1.2 KEY TRENDS ........ 70
5.12.2 THAILAND ..... 70
5.12.2.1 KEY REASONS ...... 70
5.12.2.2 KEY TRENDS ........ 71
5.12.3 SINGAPORE ........ 71
5.12.3.1 KEY REASONS ...... 71
5.12.3.2 KEY TRENDS ........ 72
5.12.4 MEXICO ........ 72
5.12.4.1 KEY REASONS ...... 72
5.12.4.2 KEY TRENDS ........ 73
5.13 MAJOR OUTBOUND MEDICAL TOURISM ANALYSIS, 2024 ........ 74
5.13.1.1 MAJOR OUTBOUND MEDICAL TOURISM ANALYSIS, 2024 ........ 74
6 GLOBAL MEDICAL TOURISM MARKET, BY TREATMENT TYPE ....... 76
6.1 OVERVIEW .... 76
6.2 ORTHOPAEDIC ....... 80
6.3 OPHTHALMOLOGY .... 82
6.4 ONCOLOGY .... 84
6.5 COSMETIC SURGERY ..... 86
6.6 CARDIOVASCULAR ........ 88
6.7 DENTISTRY ........ 90
6.8 NEUROLOGY ...... 92
6.9 FERTILITY ..... 94
6.10 OTHERS ..... 96
7 GLOBAL MEDICAL TOURISM MARKET, BY SERVICE PROVIDER .... 97
7.1 OVERVIEW .... 97
7.2 PUBLIC ....... 99
7.3 PRIVATE ........ 99
8 GLOBAL MEDICAL TOURISM MARKET, BY REGION ..... 101
8.1 OVERVIEW .... 101
8.2 NORTH AMERICA ...... 103
8.2.1 US....... 114
8.2.2 CANADA ....... 121
8.3 EUROPE ..... 129
8.3.1 GERMANY ..... 140
8.3.2 FRANCE ........ 147
8.3.3 UK ...... 155
8.3.4 ITALY ....... 163
8.3.5 SPAIN ...... 172
8.3.6 REST OF EUROPE ..... 179
8.4 ASIA-PACIFIC .... 188
8.4.1 CHINA ...... 201
8.4.2 INDIA ....... 210
8.4.3 JAPAN ..... 219
8.4.4 AUSTRALIA ........ 228
8.4.5 SOUTH KOREA .... 237
8.4.6 REST OF ASIA-PACIFIC ...... 246
8.5 REST OF THE WORLD .... 256
8.5.1 MIDDLE EAST ..... 268
8.5.2 AFRICA .... 277
8.5.2.1 TUNISIA ..... 285
8.5.2.2 MOROCCO ...... 294
8.5.2.3 KENYA ....... 302
8.5.2.4 EGYPT ....... 311
8.5.2.5 SOUTH AFRICA ..... 320
8.5.2.6 REST OF AFRICA ....... 329
8.5.3 SOUTH AMERICA ..... 338
9 COMPETITIVE LANDSCAPE .... 348
9.1 INTRODUCTION ..... 348
9.2 MARKET SHARE ANALYSIS, 2024 .... 348
9.3 COMPETITOR DASHBOARD........ 349
9.4 PUBLIC PLAYERS STOCK SUMMARY ........ 350
9.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL ........ 350
9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES ....... 351
9.6.1 RECOGNITION .... 351
9.6.2 FACILITY EXPANSION ........ 352
10 COMPANY PROFILES .... 353
10.1 APOLLO HOSPITALS ...... 353
10.1.1 COMPANY OVERVIEW ........ 353
10.1.2 FINANCIAL OVERVIEW ....... 354
10.1.3 PRODUCTS OFFERED .... 355
10.1.4 KEY DEVELOPMENTS .... 356
10.1.5 SWOT ANALYSIS ..... 357
10.1.6 KEY STRATEGIES ..... 357
10.2 BUMRUNGRAD INTERNATIONAL HOSPITAL ........ 358
10.2.1 COMPANY OVERVIEW ........ 358
10.2.2 FINANCIAL OVERVIEW ....... 359
10.2.3 PRODUCTS OFFERED .... 359
10.2.4 KEY DEVELOPMENTS .... 362
10.2.5 SWOT ANALYSIS ..... 363
10.2.6 KEY STRATEGIES ..... 363
10.3 BANGKOK HOSPITAL .... 364
10.3.1 COMPANY OVERVIEW ........ 364
10.3.2 FINANCIAL OVERVIEW..... 365
10.3.3 PRODUCTS OFFERED .... 365
10.3.4 KEY DEVELOPMENTS .... 366
10.3.5 SWOT ANALYSIS ..... 367
10.3.6 KEY STRATEGY ........ 367
10.4 RAFFLES MEDICAL GROUP ........ 368
10.4.1 COMPANY OVERVIEW ........ 368
10.4.2 FINANCIAL OVERVIEW ....... 369
10.4.3 PRODUCTS OFFERED .... 370
10.4.4 KEY DEVELOPMENTS .... 371
10.4.5 SWOT ANALYSIS ..... 371
10.4.6 KEY STRATEGIES ..... 372
10.5 ASKLEPIOS KLINIKEN GMBH & CO. KGAA .... 373
10.5.1 COMPANY OVERVIEW ........ 373
10.5.2 FINANCIAL OVERVIEW ....... 374
10.5.3 PRODUCTS OFFERED .... 375
10.5.4 KEY DEVELOPMENTS .... 375
10.5.5 KEY STRATEGIES ..... 375
10.6 MOUNT ELIZABETH HOSPITALS ....... 376
10.6.1 COMPANY OVERVIEW ........ 376
10.6.2 FINANCIAL OVERVIEW ....... 376
10.6.3 PRODUCT OFFERED ...... 377
10.6.4 KEY DEVELOPMENTS .... 377
10.6.5 KEY STRATEGIES ..... 378
10.7 MEDANTA ..... 379
10.7.1 COMPANY OVERVIEW ........ 379
10.7.2 FINANCIAL OVERVIEW ....... 380
10.7.3 PRODUCTS OFFERED .... 381
10.7.4 KEY DEVELOPMENTS .... 381
10.7.5 KEY STRATEGIES ..... 381
10.8 MANIPAL HEALTH ENTERPRISES PVT LTD ..... 383
10.8.1 COMPANY OVERVIEW ........ 383
10.8.2 FINANCIAL OVERVIEW ....... 384
10.8.3 PRODUCTS OFFERED .... 384
10.8.4 KEY DEVELOPMENTS .... 385
10.8.5 KEY STRATEGIES ..... 385
10.9 FORTIS HEALTHCARE ....... 386
10.9.1 COMPANY OVERVIEW ........ 386
10.9.2 FINANCIAL OVERVIEW ....... 387
10.9.3 SERVICES OFFERED ...... 388
10.9.4 KEY DEVELOPMENTS .... 390
10.9.5 SWOT ANALYSIS ..... 391
10.9.6 KEY STRATEGIES ..... 391
10.10 SAMITIVEJ HOSPITAL ...... 392
10.10.1 COMPANY OVERVIEW ........ 392
10.10.2 FINANCIAL OVERVIEW ....... 392
10.10.3 SERVICES OFFERED ...... 393
10.10.4 KEY DEVELOPMENTS .... 396
10.10.5 KEY STRATEGIES ..... 397
11 DATA CITATIONS ...... 398

ページTOPに戻る

List of Tables/Graphs